Literature DB >> 24856012

Renal replacement therapy: how can we contain the costs?

Raymond Vanholder1, Wim Van Biesen2, Norbert Lameire3.   

Abstract

Mesh：

Year:  2014        PMID： 24856012     DOI： 10.1016/S0140-6736(14)60721-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.

Authors:  Hui Zhang; Chao Zhang; Sufen Zhu; Hongjian Ye; Donglan Zhang
Journal:  BMC Health Serv Res       Date:  2020-02-14       Impact factor: 2.655

Review 2.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

3.  Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis.

Authors:  Francesco Ramponi; Claudio Ronco; Giacomo Mason; Enrico Rettore; Daniele Marcelli; Francesca Martino; Mauro Neri; Alejandro Martin-Malo; Bernard Canaud; Francesco Locatelli
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-22

4.  End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study.

Authors:  Ilais Moreno Velásquez; Maribel Tribaldos Causadias; Régulo Valdés; Beatriz Gómez; Jorge Motta; César Cuero; Víctor Herrera-Ballesteros
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

Review 5.  Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability.

Authors:  Christian Apel; Carsten Hornig; Frank W Maddux; Terry Ketchersid; Julianna Yeung; Adrian Guinsburg
Journal:  Clin Kidney J       Date:  2021-12-27

6.  Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025.

Authors:  Ling Sun; Lu-Xi Zou; Yu-Chen Han; Han-Ming Huang; Zhao-Ming Tan; Min Gao; Kun-Ling Ma; Hong Liu; Bi-Cheng Liu
Journal:  BMC Nephrol       Date:  2016-06-13       Impact factor: 2.388

Review 7.  The current and future landscape of dialysis.

Authors:  Jonathan Himmelfarb; Raymond Vanholder; Rajnish Mehrotra; Marcello Tonelli
Journal:  Nat Rev Nephrol       Date:  2020-07-30       Impact factor: 28.314
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.